TY - JOUR
T1 - Brain imaging of locomotion in neurological conditions
AU - Allali, Gilles
AU - Blumen, Helena M.
AU - Devanne, Hervé
AU - Pirondini, Elvira
AU - Delval, Arnaud
AU - Van De Ville, Dimitri
N1 - Funding Information:
This study was funded by the Swiss National Science Foundation (320030_173153) and by the Bertarelli Foundation Catalyst Fund (proposal number BC1708).
Publisher Copyright:
© 2018 Elsevier Masson SAS
PY - 2018/12
Y1 - 2018/12
N2 - Impaired locomotion is a frequent and major source of disability in patients with neurological conditions. Different neuroimaging methods have been used to understand the brain substrates of locomotion in various neurological diseases (mainly in Parkinson's disease) during actual walking, and while resting (using mental imagery of gait, or brain-behavior correlation analyses). These studies, using structural (i.e., MRI) or functional (i.e., functional MRI or functional near infra-red spectroscopy) brain imaging, electrophysiology (i.e., EEG), non-invasive brain stimulation (i.e., transcranial magnetic stimulation, or transcranial direct current stimulation) or molecular imaging methods (i.e., PET, or SPECT) reveal extended brain networks involving both grey and white matters in key cortical (i.e., prefrontal cortex) and subcortical (basal ganglia and cerebellum) regions associated with locomotion. However, the specific roles of the various pathophysiological mechanisms encountered in each neurological condition on the phenotype of gait disorders still remains unclear. After reviewing the results of individual brain imaging techniques across the common neurological conditions, such as Parkinson's disease, dementia, stroke, or multiple sclerosis, we will discuss how the development of new imaging techniques and computational analyses that integrate multivariate correlations in “large enough datasets” might help to understand how individual pathophysiological mechanisms express clinically as an abnormal gait. Finally, we will explore how these new analytic methods could drive our rehabilitative strategies.
AB - Impaired locomotion is a frequent and major source of disability in patients with neurological conditions. Different neuroimaging methods have been used to understand the brain substrates of locomotion in various neurological diseases (mainly in Parkinson's disease) during actual walking, and while resting (using mental imagery of gait, or brain-behavior correlation analyses). These studies, using structural (i.e., MRI) or functional (i.e., functional MRI or functional near infra-red spectroscopy) brain imaging, electrophysiology (i.e., EEG), non-invasive brain stimulation (i.e., transcranial magnetic stimulation, or transcranial direct current stimulation) or molecular imaging methods (i.e., PET, or SPECT) reveal extended brain networks involving both grey and white matters in key cortical (i.e., prefrontal cortex) and subcortical (basal ganglia and cerebellum) regions associated with locomotion. However, the specific roles of the various pathophysiological mechanisms encountered in each neurological condition on the phenotype of gait disorders still remains unclear. After reviewing the results of individual brain imaging techniques across the common neurological conditions, such as Parkinson's disease, dementia, stroke, or multiple sclerosis, we will discuss how the development of new imaging techniques and computational analyses that integrate multivariate correlations in “large enough datasets” might help to understand how individual pathophysiological mechanisms express clinically as an abnormal gait. Finally, we will explore how these new analytic methods could drive our rehabilitative strategies.
KW - Dementia
KW - Gait disorders
KW - Methods
KW - Multiple Sclerosis.
KW - Neuroimaging
KW - Neurological conditions
KW - Parkinson's disease
KW - Review
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85055587792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055587792&partnerID=8YFLogxK
U2 - 10.1016/j.neucli.2018.10.004
DO - 10.1016/j.neucli.2018.10.004
M3 - Review article
C2 - 30487063
AN - SCOPUS:85055587792
SN - 0987-7053
VL - 48
SP - 337
EP - 359
JO - Neurophysiologie Clinique
JF - Neurophysiologie Clinique
IS - 6
ER -